Keith Limbach
11Patents
5h-index
24Co-inventors
66Inventor score
Filing activity: Aug 12, 1993 → Mar 19, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5494807A | NYVAC vaccinia virus recombinants comprising heterologous inserts | Emerging Cross-Sectional Technologies | 139 | Expired |
| US5762938A | Modified recombinant vaccinia virus and expression vectors thereof | Emerging Cross-Sectional Technologies | 66 | Expired |
| US5756103A | Alvac canarypox virus recombinants comprising heterlogous inserts | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5766599A | Trova fowl pox virus recombinants comprising heterologous inserts | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5529780A | Nucleotide and amino acid sequences of canine herpesvirus gB and gC | Chemistry; Metallurgy | 12 | Expired |
| US6017542A | Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor | Chemistry; Metallurgy | 5 | Expired |
| US5688920A | Nucleotide and amino acid sequences for canine herpesvirus GB, GC and GD and uses therefor | Chemistry; Metallurgy | 1 | Expired |
| US8450055B2 | Malaria antigen screening method | Emerging Cross-Sectional Technologies | 0 | Active |
| US9694062B2 | Plasmodium falciparum sporozoite and liver stage antigens | Emerging Cross-Sectional Technologies | 0 | Active |
| US9254316B2 | Adenoviral vector-based malaria vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US9651543B2 | Malaria antigen screening method | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.